The company is highlighting CBC through its flagship Mood line, which blends the compound with CBD and hemp-derived Delta-9 THC. For those seeking alternatives without psychoactive components, the brand maintains a specialized catalog of THC-free CBC oils and gummies. This push reflects a broader industry trend where improved extraction technologies allow for the commercial availability of compounds that were previously difficult to isolate in meaningful quantities.
Rare Cannabinoid Company Shifts Focus Toward CBC in August Campaign
As consumer interest in the hemp plant evolves beyond CBD and THC, the Honolulu-based Rare Cannabinoid Company has launched a month-long educational initiative centered on cannabichromene. The campaign aims to demystify the non-intoxicating cannabinoid while promoting a diverse array of formulations to a more informed market.
Scientific interest in CBC continues to mount, particularly regarding its potential interactions with the endocannabinoid system and its relation to anandamide, often termed the body’s bliss molecule. By offering educational resources that distinguish CBC from other minor cannabinoids like THCV, CBG, and CBN, the company seeks to position itself as a primary source for consumers navigating the complex chemical profile of hemp. To incentivize this learning process, a promotional BOGO 50% off event is running throughout August, including complimentary product packets for orders exceeding $99.
Comments (0)
No comments yet. Be the first!